Eiry Roberts Neurocrine Biosciences Inc (NBIX) insider trading activity

Eiry Roberts is Chief Medical Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 35,640 shares of NBIX, which is worth approximately $4.1 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 500 shares (Common Stock) at a price of $115.04 per share, resulting in proceeds of $57,520. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.6K

14.74% 3M change

50.28% 12M change

Total Value Held $4.1 Million

EIRY ROBERTS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	SELL Open market or private sale	$57,520 $115.04 p/Share	500 Reduced 1.38%	35,640 Common Stock
Feb 13 2025	SELL Open market or private sale	$200,696 $116.82 p/Share	1,718 Reduced 4.71%	34,768 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	4,605 Added 11.3%	36,140 Common Stock
Feb 10 2025	SELL Open market or private sale	$115,855 $118.22 p/Share	980 Reduced 2.86%	33,253 Common Stock
Feb 08 2025	BUY Exercise of conversion of derivative security	-	1,860 Added 5.15%	34,233 Common Stock
Jan 31 2025	SELL Open market or private sale	$222,629 $152.8 p/Share	1,457 Reduced 4.31%	32,373 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	-	2,769 Added 7.57%	33,830 Common Stock
Nov 08 2024	BUY Exercise of conversion of derivative security	$625,794 $85.2 p/Share	7,345 Added 19.12%	31,061 Common Stock
Feb 13 2024	SELL Open market or private sale	$148,117 $132.96 p/Share	1,114 Reduced 4.49%	23,716 Common Stock
Feb 08 2024	SELL Open market or private sale	$131,525 $134.21 p/Share	980 Reduced 4.14%	22,717 Common Stock
Feb 06 2024	SELL Open market or private sale	$159,451 $142.24 p/Share	1,121 Reduced 4.88%	21,837 Common Stock
Jan 31 2024	SELL Open market or private sale	$205,131 $140.79 p/Share	1,457 Reduced 6.54%	20,832 Common Stock
Dec 22 2023	SELL Open market or private sale	$1,267,400 $126.74 p/Share	10,000 Reduced 33.87%	19,521 Common Stock
Dec 12 2023	SELL Open market or private sale	$1,675,316 $120.31 p/Share	13,925 Reduced 32.05%	29,521 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$1,128,621 $81.05 p/Share	13,925 Added 27.63%	36,468 Common Stock
Dec 08 2023	SELL Open market or private sale	$36,024 $120.08 p/Share	300 Reduced 1.01%	29,521 Common Stock
Dec 08 2023	BUY Exercise of conversion of derivative security	$24,315 $81.05 p/Share	300 Added 1.0%	29,621 Common Stock
Dec 07 2023	SELL Open market or private sale	$9,314,110 $120.37 p/Share	77,379 Reduced 72.38%	29,521 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$6,106,750 $78.92 p/Share	77,379 Added 65.2%	41,296 Common Stock
Dec 06 2023	SELL Open market or private sale	$1,007,771 $120.03 p/Share	8,396 Reduced 22.14%	29,521 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$653,292 $77.81 p/Share	8,396 Added 18.13%	37,917 Common Stock
Aug 21 2023	SELL Open market or private sale	$343,401 $107.38 p/Share	3,198 Reduced 9.77%	29,521 Common Stock
Apr 24 2023	SELL Open market or private sale	$1,490,112 $103.48 p/Share	14,400 Reduced 35.08%	26,644 Common Stock
Feb 08 2023	SELL Open market or private sale	$102,076 $104.16 p/Share	980 Reduced 2.33%	41,015 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,476,729 $102.38 p/Share	14,424 Reduced 26.44%	40,135 Common Stock

Also insider at

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

Eiry Roberts

Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account